Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04289571 · ClinicalTrials.gov registry record · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
A Phase 1 study of Cone-Rod Degeneration and Rod-Cone Degeneration, sponsored by National Eye Institute (NEI).
- Recruiting
- Registry status
- Phase 1
- Development phase
- 165
- Enrollment target
- 2
- Study locations
NCT04289571: Recruiting Phase 1 study of Cone-Rod Degeneration and Rod-Cone Degeneration, sponsored by National Eye Institute (NEI).
NCT04289571 is a Phase 1 study of Cone-Rod Degeneration and Rod-Cone Degeneration that is actively recruiting participants, run by National Eye Institute (NEI). The registered enrollment target is 165 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (175% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04289571, a Phase 1 study of Cone-Rod Degeneration and Rod-Cone Degeneration, is actively recruiting participants, sponsored by National Eye Institute (NEI).
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 165 participants
- Enrollment target
- 2
- Study locations
Study Summary
Background: The retina is a thin layer of tissue at the back of the eye. Retinal disease usually reduces a person s mobility because it affects how he or she moves through familiar and unfamiliar environments. Researchers want to see if a virtual reality (VR) tool can provide an easier and more accurate way to assess mobility. Objective: To learn if researchers can track changes in mobility in people with retinal disease using a new VR tool. Eligibility: People aged 5 and older with retinal disease that affects their vision, and healthy volunteers. Design: Participants will have 2-3 clinic visits. Participants will wear goggles or sit in front of a screen while sitting. Using a game controller, they will navigate through 4 obstacle courses presented in VR. Participants will have a medical history exam. They will answer questions about their family history. They will fill out questionnaires about the vision and mobility issues they have in their daily lives. Participants will have a complete eye exam. They will read letters from a chart. Their eye pressure will be measured. Their pupils may be dilated with eye drops. Pictures of their eye will be taken. Lights will be shined in their eyes. Participants will take a visual field test. For this, they will look into a dome and press a button when they see a light. Participants will have an electroretinogram. For this, they will sit in the dark with their eyes patched. Then their eyes will be numbed with eye drops and they will wear contact lenses while watching flashing lights. Participants will have optical coherence tomography. This is a noninvasive procedure. It produces cross-sectional pictures of the retina....
Primary Outcome
Examine the correlation between VR mobility test parameters(e.g., accuracy, task time) and the mobility score from a PRO questionnaire/s.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST VR Mobility Tool
Study Locations (2)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Other
- University of Sydney - Sydney
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2030-12-31 |
| Phase | Phase 1 |
What NCT04289571 shows while recruiting
NCT04289571 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (175% higher).
The record links to 2 conditions, with Cone-Rod Degeneration appearing as the primary indexed condition, and to 1 intervention - of which VR Mobility Tool is the first listed.
NCT04289571 reports a single indexed study location in Maryland, Other.
Frequently Asked Questions
What is clinical trial NCT04289571 about?
NCT04289571 is a clinical study titled "Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease". Background: The retina is a thin layer of tissue at the back of the eye. Retinal disease usually reduces a person s mobility because it affects how he or she moves through familiar and unfamiliar environments. Researchers want to see if a virtual reality (VR) tool can provide an easier and more acc...
What is the current status of trial NCT04289571?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 165 participants. The study started on 2023-07-25. Estimated completion is 2030-12-31.
What conditions does trial NCT04289571 study?
This clinical trial studies the following conditions: Cone-Rod Degeneration, Rod-Cone Degeneration.
What interventions are being tested in trial NCT04289571?
The interventions under investigation include: VR Mobility Tool (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04289571?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04289571 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04289571's enrollment target sits among peer trials
165 333rd of 2000 higher than 1,666 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04458584 · 165 participants
Restoration of Thumb Strength and Function in Basal Joint Arthritis: A Comparative Effectiveness Trial (RESTART)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI